Smoore International's stock surged 5.05% during intraday trading on Monday, marking a significant rebound after a period of correction.

The movement follows recent regulatory developments where the U.S. FDA approved non-tobacco flavored e-cigarettes through the PMTA review process for the first time. Smoore's underage user identification technology was reportedly a key consideration in the FDA approval process, positioning the company favorably in the regulatory landscape.

Analysts remain constructive on the company's medium-to-long-term outlook, noting that core client products and proprietary brands are expected to accelerate through the regulatory pipeline. The company is seen as a direct beneficiary of the compliant market recovery in the e-cigarette sector.